Acute Coronary Syndrome Treatment Costs from the Perspective of the Supplementary Health System | Zendy

Vanessa Teich | Zendy; Tony Piha | Zendy; L. Fahham | Zendy; Haline Bianca Squiassi | Zendy; E.D.M.P. Paloni | Zendy; Denizar Vianna Araújo | Zendy; Paulo Miranda | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Acute Coronary Syndrome Treatment Costs from the Perspective of the Supplementary Health System

Author(s) -

Vanessa Teich,

Tony Piha,

L. Fahham,

Haline Bianca Squiassi,

E.D.M.P. Paloni,

Denizar Vianna Araújo,

Paulo Miranda

Publication year - 2015

Publication title -

arquivos brasileiros de cardiologia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.4

H-Index - 53

eISSN - 1678-4170

pISSN - 0066-782X

DOI - 10.5935/abc.20150129

Subject(s) - medicine , stent , acute coronary syndrome , angioplasty , medical costs , coronary stent , artery , retrospective cohort study , emergency medicine , surgery , cardiology , health care , myocardial infarction , restenosis , economics , economic growth

Acute coronary syndrome (ACS) is defined as a "group of clinical symptoms compatible with acute myocardial ischemia", representing the leading cause of death worldwide, with a high clinical and financial impact. In this sense, the development of economic studies assessing the costs related to the treatment of ACS should be considered.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research